Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | OLFM2 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Olfm2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of OLFM2 mRNA | CTD | PMID:36331819 | OLFM2 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of OLFM2 mRNA | CTD | PMID:30165855 | OLFM2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Olfm2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to OLFM2 promoter] | CTD | PMID:19654925 | OLFM2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Olfm2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of OLFM2 mRNA | CTD | PMID:32109520 | OLFM2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Olfm2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of OLFM2 mRNA | CTD | PMID:21570461 | OLFM2 | Human | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | ISO | Olfm2 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | OLFM2 | Human | 4,4'-sulfonyldiphenol | increases methylation | EXP | | 6480464 | bisphenol S results in increased methylation of OLFM2 gene | CTD | PMID:31601247 | OLFM2 | Human | 6-propyl-2-thiouracil | increases expression | ISO | Olfm2 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of OLFM2 mRNA | CTD | PMID:24780913 | OLFM2 | Human | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of OLFM2 intron | CTD | PMID:30157460 | OLFM2 | Human | Aflatoxin B2 alpha | increases methylation | EXP | | 6480464 | aflatoxin B2 results in increased methylation of OLFM2 intron | CTD | PMID:30157460 | OLFM2 | Human | alpha-Zearalanol | multiple interactions | ISO | Olfm2 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of OLFM2 mRNA | CTD | PMID:35163327 | OLFM2 | Human | atrazine | affects methylation | ISO | Olfm2 (Rattus norvegicus) | 6480464 | Atrazine affects the methylation of OLFM2 gene | CTD | PMID:28931070 and PMID:35440735 | OLFM2 | Human | benzo[a]pyrene | decreases expression | ISO | Olfm2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of OLFM2 mRNA | CTD | PMID:22228805 | OLFM2 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of OLFM2 intron | CTD | PMID:30157460 | OLFM2 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of OLFM2 promoter | CTD | PMID:27901495 | OLFM2 | Human | benzo[e]pyrene | increases methylation | EXP | | 6480464 | benzo(e)pyrene results in increased methylation of OLFM2 intron | CTD | PMID:30157460 | OLFM2 | Human | bisphenol A | decreases expression | ISO | Olfm2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of OLFM2 mRNA | CTD | PMID:25181051 | OLFM2 | Human | bisphenol A | increases expression | ISO | Olfm2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of OLFM2 mRNA | CTD | PMID:34947998 | OLFM2 | Human | C60 fullerene | decreases expression | ISO | Olfm2 (Rattus norvegicus) | 6480464 | fullerene C60 results in decreased expression of OLFM2 mRNA | CTD | PMID:19167457 | OLFM2 | Human | cadmium dichloride | increases methylation | ISO | Olfm2 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in increased methylation of OLFM2 promoter | CTD | PMID:22457795 | OLFM2 | Human | cantharidin | increases expression | ISO | Olfm2 (Mus musculus) | 6480464 | Cantharidin results in increased expression of OLFM2 mRNA | CTD | PMID:36907384 | OLFM2 | Human | clobetasol | increases expression | ISO | Olfm2 (Mus musculus) | 6480464 | Clobetasol results in increased expression of OLFM2 mRNA | CTD | PMID:27462272 | OLFM2 | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of OLFM2 mRNA | CTD | PMID:37042841 | OLFM2 | Human | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of OLFM2 mRNA | CTD | PMID:30031762 | OLFM2 | Human | ethylparaben | decreases expression | EXP | | 6480464 | ethyl-p-hydroxybenzoate results in decreased expression of OLFM2 mRNA | CTD | PMID:37690743 | OLFM2 | Human | genistein | increases expression | ISO | Olfm2 (Mus musculus) | 6480464 | Genistein results in increased expression of OLFM2 mRNA | CTD | PMID:32186404 | OLFM2 | Human | lipopolysaccharide | increases expression | EXP | | 6480464 | Lipopolysaccharides results in increased expression of OLFM2 mRNA | CTD | PMID:35811015 | OLFM2 | Human | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | OLFM2 | Human | methapyrilene | increases methylation | EXP | | 6480464 | Methapyrilene results in increased methylation of OLFM2 intron | CTD | PMID:30157460 | OLFM2 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of OLFM2 mRNA | CTD | PMID:29067470 | OLFM2 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Olfm2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of OLFM2 mRNA | CTD | PMID:36331819 | OLFM2 | Human | perfluorooctanoic acid | multiple interactions | ISO | Olfm2 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of OLFM2 mRNA | CTD | PMID:35163327 | OLFM2 | Human | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | OLFM2 | Human | serpentine asbestos | increases methylation | EXP | | 6480464 | Asbestos and Serpentine results in increased methylation of OLFM2 gene | CTD | PMID:29523930 | OLFM2 | Human | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide analog results in decreased expression of OLFM2 mRNA | CTD | PMID:25895662 | OLFM2 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of OLFM2 mRNA | CTD | PMID:29301061 | OLFM2 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of OLFM2 mRNA | CTD | PMID:38568856 | OLFM2 | Human | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of OLFM2 mRNA | CTD | PMID:31533062 | OLFM2 | Human | thioacetamide | decreases expression | ISO | Olfm2 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of OLFM2 mRNA | CTD | PMID:23411599 | OLFM2 | Human | titanium dioxide | decreases methylation | ISO | Olfm2 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of OLFM2 gene | CTD | PMID:35295148 | OLFM2 | Human | trichloroethene | increases expression | ISO | Olfm2 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of OLFM2 mRNA | CTD | PMID:33387578 | OLFM2 | Human | triclosan | increases expression | EXP | | 6480464 | Triclosan results in increased expression of OLFM2 mRNA | CTD | PMID:30510588 | OLFM2 | Human | triptonide | increases expression | ISO | Olfm2 (Mus musculus) | 6480464 | triptonide results in increased expression of OLFM2 mRNA | CTD | PMID:33045310 | OLFM2 | Human | valproic acid | affects expression | ISO | Olfm2 (Mus musculus) | 6480464 | Valproic Acid affects the expression of OLFM2 mRNA | CTD | PMID:17963808 | OLFM2 | Human | vinclozolin | increases methylation | ISO | Olfm2 (Rattus norvegicus) | 6480464 | vinclozolin results in increased methylation of OLFM2 gene | CTD | PMID:31682807 | |